Log in
Enquire now
Bioblast Pharma

Bioblast Pharma

Bioblast Pharma is a Tel Aviv, Israel-based biotechnology company developing therapeutic solutions for the treatment of rare genetic diseases.

OverviewStructured DataIssuesContributors

Contents

bioblast-pharma.com
bioblastpharma.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biology
Biology
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Biotechnology
Biotechnology
Location
New Haven, Connecticut
New Haven, Connecticut
‌
Tel Aviv, Tel Aviv, Israel
Tel Aviv
Tel Aviv
B2X
B2C
B2C
0
B2B
B2B
CEO
‌
Dalia Megiddo
Founder
‌
Dalia Megiddo
Pitchbook URL
pitchbook.com/profiles.../61487-74
Legal Name
Bioblast Pharma Ltd.
Legal classification
Limited company
Limited company
Date Incorporated
January 22, 2012
Number of Employees (Ranges)
11 – 500
Email Address
Phone Number
Full Address
35 Ahad Ha'am Street Tel Aviv 6520206 Israel
CIK Number
1,596,812
Founded Date
January 1, 2012
Total Funding Amount (USD)
11,449,999
Latest Funding Round Date
March 2016
Patents Assigned (Count)
4
Country
Israel
Israel

Other attributes

Company Operating Status
Active
Wikidata ID
Q30286768

Bioblast Pharma is a clinical-stage biotechnology company specializing in the development of therapeutic solutions for patients with rare genetic diseases. The company was founded by Dalia Megiddo in 2012 in Tel Aviv, Israel.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Bioblast Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.